Intellia Therapeutics officer proposes 9,000-share sale

Intellia officer and director John M. Leonard also reported sales of 19,890 shares on August 20, 2026, and 2,789 on August 21, 2026.

Available on EDGAR 11/02/2026 - 04:15 PM EST Accepted by SEC EDGAR 11/02/2026 - 04:15 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Intellia Therapeutics, Inc. officer and director John M. Leonard reported a proposed sale of 9,000 common shares through UBS Financial Services, Inc., with an approximate aggregate market value of $113,400.00 and an approximate sale date of November 2, 2026. Leonard acquired the shares through an issuer stock-option exercise on February 9, 2021. The notice also lists sales of 19,890 shares for $250,683.26 on August 20, 2026, and 2,789 shares for $36,205.00 on August 21, 2026.

Key Figures

Proposed shares for sale: 9,000 shares Approximate aggregate market value: $113,400.00 Issuer shares outstanding: 140,126,693 shares +4 more

7 metrics

Proposed shares for sale 9,000 shares Common shares; proposed sale

Approximate aggregate market value $113,400.00 Proposed sale

Issuer shares outstanding 140,126,693 shares Reported in the securities information

Shares sold August 20, 2026 19,890 shares Reported sale

Aggregate value of shares sold August 20, 2026 $250,683.26 Reported sale

Shares sold August 21, 2026 2,789 shares Reported sale

Aggregate value of shares sold August 21, 2026 $36,205.00 Reported sale

Key Terms

Rule 144, Stock Option Exercise, Aggregate market value

3 terms

Rule 144 regulatory

"definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Option Exercise financial

"Stock Option Exercise"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Aggregate market value financial

"Aggregate market value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NTLA shares did John M. Leonard propose to sell?

John M. Leonard reported a proposed sale of 9,000 common shares through UBS Financial Services, Inc., with an approximate sale date of November 2, 2026, and an approximate aggregate market value of $113,400.00.

What earlier NTLA share sales did John M. Leonard report?

He reported selling 19,890 shares for $250,683.26 on August 20, 2026, and 2,789 shares for $36,205.00 on August 21, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001563584
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Intellia Therapeutics, Inc.
SEC File Number	001-37766
Address of Issuer	400 TECHNOLOGY SQUARE SUITE 100 CAMBRIDGE MASSACHUSETTS 02139
Phone	857-285-6200
Name of Person for Whose Account the Securities are To Be Sold	LEONARD JOHN M
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	9000	113400.00	140126693	11/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/09/2021	Stock Option Exercise	Issuer			9000	02/09/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
John M Leonard 400 Technology Square Suite 100 Cambridge MA 02139	Common	08/20/2026	19890	250683.26
John M Leonard 400 Technology Square Suite 100 Cambridge MA 02139	Common	08/21/2026	2789	36205.00

144: Remarks and Signature

Remarks
Date of Notice	11/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/21/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for John Leonard
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)